Literature DB >> 1361005

Rare expression of the c-erbB-2 oncoprotein in salivary gland tumors: an immunohistochemical study.

P Shrestha1, J W Huang, T Tsuji, F Shinozaki, K Maeda, K Sasaki, K Ueno, K Yamada, M Mori.   

Abstract

An immunohistochemical study of c-erbB-2 oncoprotein expression was carried out on 201 cases of primary salivary gland tumors, using a polyclonal antibody, raised to the intracytoplasmic domain of the c-erbB-2 oncogene product. An intense membrane reactivity was observed in one case of sialocarcinoma transformed from pleomorphic adenoma (n = 8) and one case of mucoepidermoid carcinoma (n = 22). A comparative histopathologic evaluation of c-erbB-2 positive tumors showed marked variation in cell size, nuclear pleomorphism, multinucleation, a high mitotic rate and increased lymphoid cell infiltration and an aggressive clinical course with poor survival. The results indicate that c-erbB-2 oncoprotein is rarely expressed in malignant salivary gland tumors. However, the overexpression appears to have a distinct histopathologic feature, but a larger study incorporating histopathology and clinical data would be necessary to correlate the significance of c-erbB-2 oncogene product in salivary malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361005     DOI: 10.1111/j.1600-0714.1992.tb00978.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  4 in total

1.  Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.

Authors:  J C Rosa; A Félix; I Fonseca; J Soares
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumour stage, and cell proliferation in malignant salivary gland tumours.

Authors:  N Kamio
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

3.  Correlation of c-erbB-2 and S-100 expression with the malignancy grading and anatomical site in oral squamous cell carcinoma.

Authors:  Ricardo L C Albuquerque; Márcia C C Miguel; Antonio L L Costa; Lélia B Souza
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

Review 4.  Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Authors:  Aymen Lagha; Nesrine Chraiet; Mouna Ayadi; Sarra Krimi; Bassem Allani; Hela Rifi; Henda Raies; Amel Mezlini
Journal:  Head Neck Oncol       Date:  2012-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.